Results 311 to 320 of about 71,029 (345)
Some of the next articles are maybe not open access.

Chronic Myelomonocytic Leukaemia and Atypical Chronic Myeloid Leukaemia

1992
Chronic myelomonocytic leukaemia (CMML) has attracted interest in two contexts in recent years. First, the FAB Cooperative Group [3] has classified it as a myelodysplastic syndrome (MDS) characterised by the presence in the peripheral blood of more than 1.0 × 109/1 monocytes but otherwise identical with one of the named variants of MDS, except in those
I. Krsnik   +2 more
openaire   +1 more source

Chronic myeloid leukemia

European Journal of Cancer, 2001
Tariq I. Mughal, John M. Goldman
openaire   +1 more source

Chronic myeloid leukaemia: Biology and therapy

Blood Reviews
Chronic myeloid leukaemia (CML) is caused by BCR::ABL1. Tyrosine kinase-inhibitors (TKIs) are the initial therapy. Several organizations have reported milestones to evaluate response to initial TKI-therapy and suggest when a change of TKI should be considered.
Yun, Wang   +7 more
openaire   +2 more sources

Onconephrology: The intersections between the kidney and cancer

Ca-A Cancer Journal for Clinicians, 2021
, Kenar D Jhaveri, Mark A Perazella
exaly  

Intermittent fasting in the prevention and treatment of cancer

Ca-A Cancer Journal for Clinicians, 2021
Katherine Clifton   +2 more
exaly  

Chronic Myeloid Leukaemia

Australian and New Zealand Journal of Medicine, 1981
openaire   +2 more sources

Chronic myeloid leukaemia

Medicine
Samantha Drummond, Mhairi Copland
openaire   +2 more sources

Treatment of chronic myeloid leukaemia

Baillière's Clinical Haematology, 1987
N C, Allan, P C, Shepherd
openaire   +2 more sources

Home - About - Disclaimer - Privacy